Clinical Trial Update: Oxaliplatin and Paclitaxel in Treating Patients With Locally Recurrent or Metastatic Cervical Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the combination of oxaliplatin and paclitaxel for locally recurrent or metastatic cervical cancer; results have been posted following c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Adenocarcinoma
• Cervical Adenosquamous Carcinoma
• Cervical Cancer
• Cervical Squamous Cell Carcinoma
• Stage Iva Cervical Cancer
• Stage Ivb Cervical Cancer

Drugs mentioned

• Oxaliplatin (Eloxatin) (oxaliplatin)
• Paclitaxel (Taxol) (paclitaxel)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2015-11-17